Mandall 2014
Mandall 2014
OnlineFirst
    © The Author(s) 2024, Article Reuse Guidelines
    https://doi.org/10.1177/14653125241255139
Clinical Section
Nicky Mandall 1, Wesam Aleid 2, Richard Cousley 3, Edith Curran 1, Susi Caldwell 4,
Andrew DiBiase 5, Fiona Dyer 6, Simon Littlewood 7, Spencer Nute 8, Sarah Jayne
    Campbell 9, Simon Atkins 10, Sherif Bayoumi 2, Vyomesh Bhatt 8, Paul Chambers 7, Nicholas
    Goodger 5, Claire Bates 1, Ovais Malik 11, David Waring 9, and Paul Bassett 12
    Objective: To evaluate the effectiveness of bone anchored maxillary protraction (BAMP) in the
    management of class III skeletal malocclusion in children aged 11–14 years compared with an
    untreated control group in terms of perceived need for orthognathic surgery, skeletal and dental
    change, and psychological impact.
    Design: A multicentre two-armed parallel randomised controlled trial.
    Setting: Six UK hospital orthodontic units.
    Methods: A total of 57 patients were randomly allocated into either the BAMP group (BAMPG)
    (n = 28) or a no treatment control group (CG) (n = 29).
    Outcomes: Data collection occurred at registration (DC1),18 months (DC2) and 3 years (DC3),
    where skeletal and dental changes were measured from lateral cephalograms and study models.
    Oral Aesthetic Subjective Impact Score (OASIS) and Oral Quality of Life (OHQOL)
    questionnaires were used to assess the psychological impact of treatment.
    Results: The mean age was 12.9 ± 0.7 years and 12.6 ± 0.9 years in the BAMPG and CG,
    respectively. At DC2, the BAMPG achieved a class III ANB improvement of +0.6° compared
    with −0.7° in the CG (P = 0.004). The overjet improvement was +1.4 mm for the BAMPG and
    −0.2 mm for the CG (P = 0.002). There was no evidence of any other group differences for the
    other skeletal or dental cephalometric outcomes (P > 0.05) or the questionnaire data (OASIS P =
    0.10, OHQOL P = 0.75). At DC2, the 18-month follow-up, 22% of the BAMPG achieved a
    positive overjet. At the 3-year follow-up (DC3), fewer patients in the BAMPG were perceived to
    need orthognathic surgery (48%) compared with 75% of patients in the CG (P = 0.04), with an
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                         26/07/24, 11 22 PM
                                                                                              Page 1 of 21
:
    odds ratio of 0.31 (95% confidence interval = 0.10–0.95).
    Conclusion: The BAMP technique did not show any social or psychological benefits; however,
    the skeletal class III improvement in ANB and the overjet change were sufficient to reduce the
    perceived need for orthognathic surgery by 27% compared with the CG.
    Keywords
    class III skeletal pattern, bone anchored maxillary protraction, skeletal and dental outcomes,
    randomised controlled trial
    Corresponding author(s):
    Nicky Mandall, Tameside and Glossop Integrated Care NHS Foundation Trust, Fountain Street, Ashton-under-Lyne,
    Manchester OL6 9RW, UK. Email: nicky.mandall@tgh.nhs.uk
    Introduction
    Treatment for young children with a skeletal class III malocclusion can be limited to an upper
    arch alignment while waiting until facial growth is mostly complete, before offering either
    orthodontic camouflage or orthognathic surgery. Skeletal surgical bone anchor systems have
    been described for young teenagers, either for absolute orthodontic anchorage or for orthopaedic
    maxillary protraction (Choi et al., 2005; Cornelis et al., 2008a; De Clerck et al., 2002, 2009;
    Eroglu et al., 2010; Heymann et al., 2010; Kircelli and Pektas, 2008; Liou, 2005; Mommaerts et
    al., 2005; Singer et al., 2000; Sugawara and Nishimura, 2005).
         The bone anchored maxillary protraction (BAMP) technique consists of miniplates in the
    anterior zygomatic arches and distal to the lower permanent canines (Figure 1) with full-time
    class III elastics (150–200 g) to protract the maxilla. De Clerck et al. (2010) showed a mean
    sagittal maxillary improvement of 5.2 mm in consecutively treated BAMP cases, which was 3.9
    mm better than an untreated group (P < 0.001). The overjet correction was 3.8 mm more than in
    the untreated group (P < 0.001). Similarly, Nguyen et al. (2011) reported a forward maxillary
    displacement of 3.7 mm and 4.3 mm upper incisor movement. Slightly larger treatment effects
    were seen after a randomised controlled trial (RCT) using a modified technique of palatal
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                                     26/07/24, 11 22 PM
                                                                                                          Page 2 of 21
:
    miniscrew-anchored maxillary protraction (MAMP) (Kamel et al., 2023) with 4.34 mm of
    maxillary protraction and an ANB improvement of 5.5°. Van Hevele et al. (2018) showed
    smaller BAMP SNA and ANB improvements of 1.9° and 1.4°, respectively. Skeletal effects were
    also shown at the circum-maxillary sutures, pterygomaxillary fissure (Baccetti et al., 2010) and
    the glenoid fossa (De Clerck et al., 2012; Yatabe et al., 2017a) and were reflected in
    improvements in the upper lip, cheeks and midface soft tissue (Elnagar et al., 2017a). The BAMP
    technique is also effective for children with unilateral cleft lip and palate (Faco et al., 2019 Ren
    et al., 2019; Yatabe et al., 2017b) and successfully improves the airway in young patients with
    obstructive sleep apnoea (Quo et al., 2019).
    When maxillary protraction treatments are compared, BAMP appears to be more effective than a
    tooth-borne protraction facemask (Cevidanes et al., 2010; Cha and Ngan, 2011; Elnagar et al.,
    2017b; Sar et al., 2011). A systematic review (Feng et al., 2012) reported a mean of 3.08 mm
    forward movement of A point in the BAMP group compared with untreated controls (P < 0.001)
    and BAMP was 1.4 mm more effective than a protraction facemask (P = 0.003). Another
    systematic review (Morales-Fernandez et al., 2013) showed the BAMP protraction effect was on
    average 5.2 mm compared with 0.81 mm for a protraction facemask. They also reported a mean
    angular skeletal change in the BAMP patients of 2.53° protraction at A point, a 1.93° retraction
    at B point and a class III improvement of 4.46°. It is interesting to then consider the meta-
    analysis by Cornelis et al. (2021) that suggested a bone-anchored facemask (ANB correction
    4.2°) and BAMP with class III elastics (ANB correction 3.5°) seemed to deliver a similar
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                             26/07/24, 11 22 PM
                                                                                                  Page 3 of 21
:
    maxillary protraction effect.
        Although there is evidence to support the effectiveness of BAMP and comparison with other
    maxillary protraction treatments, we aimed to prospectively randomise to compare BAMP with
    an untreated control group and to further evaluate the need for orthognathic surgery with a long-
    term follow-up.
        Therefore, the aim of the present study was to evaluate the effectiveness of BAMP in children
    aged 11–14 years, compared with an untreated control group, in terms of skeletal and dental
    change, psychological impact and the need for orthognathic surgery. The null hypothesis stated
    that there was no difference in the effectiveness of BAMP in children aged 11–14 years,
    compared with an untreated control group, in terms of skeletal and dental change, psychological
    impact and the need for orthognathic surgery.
    Methods
    The study was a multicentre two-arm parallel RCT with a 1:1 allocation ratio for two groups. No
    changes to the trial were made after commencement.
    Participants
    Inclusion criteria. The inclusion criteria were as follows: White Caucasian children aged 11.5–
    14.0 years (the lower age limit was advised particularly for girls where lack of bone density
    increases the risk of plate failure); a class III skeletal pattern with maxillary retrusion; a reverse
    overjet of at least −1 mm with three or more incisors in crossbite in retruded contact position;
    lower permanent canines and first premolars erupted (to allow space for the lower plates after
    orthodontic root divergence); and dentally fit and excellent oral hygiene (to reduce the risk of
    postoperative infection).
    Exclusion criteria. The exclusion criteria were as follows: cleft lip and/or palate or craniofacial
    syndrome (maxillary soft tissue scarring may reduce the effect of maxillary protraction); a
    reverse overjet greater than −6 mm (De Clerck et al. (2010) showed a mean overjet correction of
    4 ± 1.9 mm, suggesting a maximum overjet correction achievable with this technique of
    approximately 6 mm; a forward mandibular displacement on closure (the presence of a forward
    mandibular displacement on closure in some of the patients may complicate the statistical
    analysis); a maxillary mandibular planes angle >38° (the BAMP treatment may have resulted in a
    downwards and backwards mandibular rotation and increase in lower face height); mandibular
    asymmetry; muscular dystrophy (associated with increased lower face height and it was possible
    the BAMP technique could further increase the lower face height); previous radiotherapy to
    jaws; previous or current treatment with bisphosphonates; and smoking (these factors may affect
    surgical infection and healing).
Study setting
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                              26/07/24, 11 22 PM
                                                                                                   Page 4 of 21
:
    Patients were recruited from general dental practitioner referrals to orthodontic departments at
    six UK hospitals: Tameside General Hospital, Manchester (n = 15); Wythenshawe Hospital,
    Manchester (n = 8); Southend University Hospital (n = 2) and Charles Clifford Dental Hospital,
    Sheffield (n = 11); William Harvey Hospital, Kent (n = 11); and St Luke’s Hospital, Bradford (n
    = 10). The consultant orthodontist at each site was the local principal investigator (PI) and was
    responsible for patient recruitment and consent. The approvals obtained were novel BAMP
    technique, ethics committee (MREC 15/NW/0022) and Research and Development. Patients
    were registered between March 2016 and October 2019.
    The clinical endpoint was defined as achieving a positive overjet of 1 mm or more. If the clinical
    endpoint was not reached, elastic wear continued until the DC2 timepoint, 18 months after the
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                           26/07/24, 11 22 PM
                                                                                                Page 5 of 21
:
    baseline registration, at which point the plates were removed.
        Between the DC2 and DC3 timepoints, if the consultant orthodontist considered an upper
    fixed appliance was clinically indicated, then this was carried out and documented. The use of an
    upper fixed appliance was then accounted for in the statistical analysis.
    Outcome measures
    Primary outcome measure: Perceived need for orthognathic surgery. The primary outcome
    measure was the need for orthognathic surgery. The evaluation of perceived clinical need for
    orthognathic surgery was assessed by a group of three consultant orthodontists who were not
    involved in the BAMP clinical trial delivery (CB, OM, DW) who discussed and reached a
    consensus regarding the perceived need for orthognathic surgery as ‘yes’ or ‘no’. They assessed
    blinded DC3 records: extra-oral and intra-oral photographs; clinical overjet measurement; and
    cephalometric measures. The following factors were used for orthognathic decision making: the
    extent of skeletal class III (SNA, SNB and ANB); dentoalveolar: incisor inclinations
    (compensation), overbite, anterior crossbite; and soft tissues: facial profile, peri-alar recession,
    upper labial flatness, nasolabial angle, facial convexity, chin prominence and chin/neck distance.
    Secondary outcome measures: Surgical. For the BAMPG only, the patient recorded daily
    postoperative discomfort for 2 weeks (9-point Likert scale where 1 = no pain and 9 = severe
    pain). The surgeons recorded theatre operating time, in minutes, from first flap incision to final
    suture placement, postoperative infection rates and plate failure rates. There were no changes to
    the trial outcomes after the trial commenced.
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                             26/07/24, 11 22 PM
                                                                                                  Page 6 of 21
:
    Sample size calculations
    Primary outcome need for orthognathic surgery. In a trial investigating protraction headgear
    (Mandall et al., 2016), 67% of patients in the CG needed orthognathic surgery and we assumed it
    would be similar for the CG in this trial. Of the patients receiving protraction headgear, 33%
    needed surgery; however, as BAMP treatment is more effective, it was suggested that 25% of the
    BAMP group would need orthognathic surgery. A sample size of 26 individuals in each group
    would have an 80% power for a two-sample comparison of a difference in proportions of 0.42
    for patients requiring orthognathic surgery (the difference between a BAMPG proportion of 0.25
    and a CG proportion of 0.67) using a two-group test with a 0.050 two-sided significance level.
    Secondary outcome overjet. De Clerck et al. (2010) showed a mean correction of 4 mm for
    BAMP and −0.1 mm for a matched historical control. Using these data, a sample size of 4 in each
    group will have an 80% power to detect a difference in means of 4 mm (the difference between a
    BAMPG treatment mean overjet improvement of 4 ± 1.9 mm and a CG improvement of 0 ± 0.6
    mm) using a two-group t-test with a 0.05 two-sided significance level.
        Therefore, using the larger sample size calculation for the primary outcome (need for
    orthognathic surgery), 26 patients in each group meant the total sample size needed for this trial
    was 52. A total of 57 patients were to be recruited, allowing for an 8% attrition.
    Blinding
    It was not possible to blind the operator or the patients to the treatment allocation. However, this
    trial was single blind, for observers measuring the radiographs and study models and the
    statistician were blind to the treatment allocation until the analysis was completed.
    Stopping rules
    This was defined as identification of a problem with the BAMP surgical procedure, such as
    excessive pain, relapse or patient dissatisfaction.
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                             26/07/24, 11 22 PM
                                                                                                  Page 7 of 21
:
    treatment, it was planned to collect DC2 and DC3 data. It was not possible to collect data for
    patients who did not attend their appointments.
    Statistical analysis
    SPSS version 25 (IBM Corp., Armonk, NY, USA) was used. A descriptive analysis was carried
    out of the demographic characteristics of the study participants in each group. The Bland–
    Altman levels of agreement and the intraclass correlation (ICC) were used to examine intra-
    examiner reliability. Changes in the outcomes over time were calculated from DC1 to DC2 and
    then DC2 to DC3 and the changes compared between the BAMPG and the CG. For most of the
    outcomes, the analyses were performed using analysis of covariance (ANCOVA). In these
    analyses, the DC2 or DC3 value was considered to be the outcome value, with the equivalent
    outcome at baseline (DC1) included as a covariate. The exception to this method of analysis was
    for maxillary and mandibular rotation. For these outcomes, there were no baseline values, and so
    an unpaired t-test was used to compare the BAMPG and CG. All analyses were carried out at a
    level of significance of 0.05.
    Results
    Patients were recruited into the trial and randomised into the BAMPG (n = 28) or CG (n = 29).
    Figure 2 shows the trial profile and the dropouts from each group because of non-attendance. An
    intention-to-treat analysis was carried out and all patients allocated to the BAMPG received the
    surgical intervention. Baseline characteristics are shown in Table 2 and it was considered that
    pre-treatment equivalence occurred, since there was insufficient evidence of a difference between
    the BAMPG and the CG.
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                          26/07/24, 11 22 PM
                                                                                               Page 8 of 21
:
    Figure 2. Trial profile CONSORT 2010 flow diagram.
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139   26/07/24, 11 22 PM
                                                                        Page 9 of 21
:
    Descriptive statistics
    Demographics. The mean age in the BAMPG was 12.9 ± 0.7 years and in the CG it was 12.6 ±
    0.9 years. Overall, approximately two-thirds of patients were boys and one-third third were girls.
    Reliability. Reliability was measured for all cephalometric and dental overjet measurements. The
    intra-examiner reliability was high. For the 95% limits of agreement, this ranged from the
    narrowest limits of −0.4 to 0.5 through to the widest limits of −3.7 to 4.0. For the ICCs, the
    lowest value was 0.91 (95% confidence interval [CI] = 0.79–0.96) and the highest value was
    0.99 (95% CI = 0.98–1.00).
Surgical data. The mean time to place the BAMP plates was 88 ± 65 min and the mean
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                            26/07/24, 11 22 PM
                                                                                                Page 10 of 21
:
    postoperative pain score was 2.4 ± 0.67). The plate infection rate was 11.1% (a mix of upper and
    lower plates) and the plate failure rate, defined as requiring replacement, was 8.3%, exclusively
    in the upper. In total, 7 (26%) patients returned to theatre once to have an upper plate replaced
    and 1 (4%) patient had two upper plates replaced. Loss of a single screw or gingival overgrowth
    or a screw dehiscence were observed in 4 (15%) patients.
    Orthodontic data. The mean class III elastic force used for the BAMPG was 193 ± 26 g. The
    mean time in elastics was 11.4 ± 2.8 months carried out over six outpatient visits (range 6–7
    visits). In 33% of patients, it was necessary to prop the occlusion with a lower removable
    appliance and posterior occlusal bite blocks.
    Clinical and psychological changes DC1 (baseline) to DC2 (18-month follow-up). Table 3
    shows the mean SNA moved forwards in the BAMPG by 1.1° ± 1.7° compared with 0.4° ± 0.9°
    in the CG (P = 0.05; 95% CI = 0.0–1.5). Small changes in mean SNB occurred where the
    BAMPG moved forwards by 0.5° ± 1.3° compared with 1.1° ± 2.0° in the CG (P = 0.16; 95% CI
    = −1.6–0.3). For ANB, the BAMPG improved (became less class III) by a mean of 0.6° ± 1.3°
    and the CG worsened by −0.7° ± 1.2° (P = 0.004; 95% CI = 0.3–1.7). No other cephalometric
    measures showed a statistically significant difference between groups. Over time, the CG
    negative overjet worsened by −0.2 ± 1.1 mm and the BAMPG overjet improved by 1.4 ± 2.1 mm
    (P = 0.002; 95% CI = 0.6–2.4). There were no statistically significant differences between the
    BAMPG + CG for the psychological/social questionnaires (OHQOL P = 0.75; OASIS P = 0.10).
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                          26/07/24, 11 22 PM
                                                                                              Page 11 of 21
:
    The perceived need for orthognathic surgery (DC3). Patients were assessed regarding
    perceived need for orthognathic surgery at DC3, or 3 years after baseline registration. Therefore,
    the mean age in the BAMPG was 15.9 years and in the CG it was 15.6 years. An important
    finding was that statistically significantly fewer patients in the BAMPG were perceived to need
    orthognathic surgery (48%) compared with the CG (75%) (P = 0.04). This is also clinically
    significant, indicating a 27% reduction in the perceived need for orthognathic surgery for
    children who received BAMP treatment. The odds ratio (expressed as BAMP/control) was 0.31
    (95% CI = 0.10–0.95); therefore, for a group of patients, the BAMPG had approximately one-
    third of the odds of needing orthognathic surgery as the control group.
    Clinical and psychological changes DC2 (18-month follow-up) to DC3 (3-year follow-
    up). Table 4 summarises the skeletal and overjet changes from DC2 to DC3. A reduced dataset is
    shown because the other cephalometric variables changed approximately by 1° over the DC2 to
    DC3 period and the changes were neither clinically nor statistically significantly different
    between groups (P > 0.05). No rotational changes occurred in the BAMPG compared with the
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                           26/07/24, 11 22 PM
                                                                                               Page 12 of 21
:
    CG at any timepoint. SNA and SNB showed approximately 1° of forward growth from 18
    months to 3 years in both groups (P > 0.05). Similar trends were seen for overjet change with the
    BAMPG improving 0.6 mm and the CG improving 0.1 mm (P > 0.05). There were improved
    psychological outcomes for OHQOL where the BAMPG showed a 3-point reduction in the
    impact of their malocclusion compared with an increased score of 5 points in the CG (P = 0.02;
    95% CI = −18.6 to −1.9).
    The potential confounding effect of increased use of an upper fixed appliance in the BAMPG
    DC2 to DC3. Between DC2 and DC3, 52% of the BAMPG received an upper fixed appliance
    compared with 25% of the CG. As more patients in the BAMPG received an upper fixed
    appliance than in the CG, this may have influenced the tendency for the BAMPG overjet to
    improve from −1.2 mm at DC2 to −0.6 mm at DC3 whereas the CG showed no overjet
    improvement during this time. Observation of the inclination of the upper incisors (Table 4) did
    not suggest the fixed appliance had proclined the upper incisors more in the BAMPG to explain
    the overjet improvement. Further ANCOVA testing did not indicate that the increased use of an
    upper fixed appliance influenced the overjet improvement in the BAMPG compared with the CG
    (P = 0.09). In contrast, the mean difference between groups for the change in the OHQOL
    questionnaire DC2-DC3 was influenced by the use of an upper fixed appliance (P = 0.04). In
    other words, the increased use of an upper fixed appliance in the BAMPG during DC2-DC3 is
    more likely to explain the improved OHQOL score. This is particularly since the DC3 3-year
    follow-up data were collected after the fixed appliance was debonded, where OHQOL scores
    would be expected to improve at the end of treatment.
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                          26/07/24, 11 22 PM
                                                                                              Page 13 of 21
:
    Discussion
    This trial has shown that the BAMP treatment results in a small but favourable improvement in
    ANB and overjet for class III skeletal malocclusions in children aged 11.5–14 years. An example
    of the type of changes are shown in Figure 3. At the 3-year follow-up, just before the age of 16
    years, the BAMPG had a 27% lower perceived need for orthognathic surgery compared with the
    untreated CG. This is the first RCT to report a long-term perceived need for orthognathic surgery
    outcome.
Figure 3. (a) Baseline DC1. (b) After 9 months of elastic wear. (c) DC3, at the 3-year follow-up.
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                                   26/07/24, 11 22 PM
                                                                                                       Page 14 of 21
:
    class III ANB improvement of 4.46° (0.6° in this study). However, the BAMP treatment effect is
    more favourable than this latter value would suggest when compared with a worsening of ANB
    of −0.7° in the CG, giving an overall ANB treatment effect of 1.3° (the difference between +0.6°
    BAMPG and −0.7° CG). The change in overjet for the BAMPG in this trial was on average +1.4
    mm and smaller than the +4 mm movement reported by De Clerck et al. (2010). It is possible
    that the reason for the smaller ANB and overjet improvements was a result of the prospective
    and randomised methodology. Prospective randomisation should minimise potential selection,
    information or confounding bias that may result in reporting larger treatment effects.
        A further explanation for the smaller skeletal changes shown in this trial could be the
    difference in healthcare systems. Private healthcare may result in increased motivation and
    children wearing their elastics more successfully. It was not possible for us to accurately measure
    compliance with elastic wear, although 3 (12%) patients in the BAMPG were recorded as
    struggling with elastic wear.
        A further factor that may limit compliance with elastic wear could be loose or infected plates.
    The plate infection rate in this study was 11.1%. Our plate failure rate was 8.3% and compared
    favourably with the range of 6.6%–38.5% for the same pre-drilled self-tapping technique
    (Cornelis et al., 2008a; Mommaerts et al., 2014; Van Hevele et al., 2018). Therefore, it seems
    unlikely that the plate failure rate in this study could have influenced elastic wear enough to
    explain the smaller skeletal movements.
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                             26/07/24, 11 22 PM
                                                                                                 Page 15 of 21
:
    et al., 2017).
        A further consideration is that we did not collect data on whether the patient might consider
    orthognathic surgery when they are older through longer-term follow-up. This study did not
    establish who went ahead with orthognathic surgery. As the final data were completed just before
    the age of 16 years, there is also likely to be further class III growth in many of the patients; this
    may affect their decision to go ahead with surgery at a later date. With further class III growth, it
    may also be possible that more patients would clinically be perceived to need orthognathic
    surgery so this study may have underestimated this outcome at the DC3 time point.
    Risk/benefit
    A number of factors will influence the risk/benefit considerations for the BAMP technique. It
    was observed that all the plate failures occurred in the upper plates and this was not surprising
    given that they are technically more difficult to place because of the anatomy of the anterior
    zygomatic arch and the proximity to the maxillary sinus where the bone is thinner. A prospective
    RCT compared MAMP, a palatal mini-screw supported hybrid hyrax screw and a bone supported
    mandibular bar, and an untreated CG (Kamel et al., 2023). They showed favourable mean ANB
    changes of 5.5° in the MAMP group compared with a worsening of −0.61° in the CG at 12-
    month follow-up. This is supported by the meta-analysis carried out by Cornelis et al. (2021),
    who showed a bone anchored facemask treatment delivered similar maxillary protraction to
    BAMP with class III elastics. These findings would support the use of palatal mini-screw
    retained RME (MAMP) rather than the upper miniplates being sited in the anterior zygomatic
    arches used in this study. This would also benefit the patient in terms of shorter operating time,
    less surgical morbidity and recovery time, and a reduced need for repeat surgery to replace loose
    upper plates.
        There was a complication for one patient in the BAMPG because of COVID-19 pandemic
    delays. As they waited 18 months to have the plates removed, one lower plate was ankylosed
    with significant bony overgrowth. It was left in-situ subgingivally but highlights the need to
    remove the plates soon after elastic wear is completed.
        Postoperative discomfort scores are also considered a risk. Patients and parents should be
    aware of postoperative discomfort as part of informed consent. The discomfort levels recorded
    were similar to previous reports (Cornelis et al., 2008b), so we can be reassured that pain levels
    are low with the BAMP technique. Cornelis et al. (2008a) reported the time in surgery for plate
    placement as 15–30 min per plate and this compares favourably with our data (mean time to
    place four plates was 88 min).
        It is also important that the BAMP treatment in this trial did not show a demonstrable patient
    psychosocial benefit. This could be explained by the small skeletal and overjet changes that,
    although noticed by clinicians, may not be as obvious to the patients.
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                              26/07/24, 11 22 PM
                                                                                                  Page 16 of 21
:
    The finding that the BAMPG was perceived to need orthognathic surgery in 48% of cases
    compared with 75% in the CG is clinically significant and, arguably, BAMP, or a modified
    technique (MAMP) as discussed earlier, should be routinely considered offered to children aged
    11.5–14 years with a class III skeletal pattern. An added advantage of MAMP is the ability to
    expand the upper arch during maxillary protraction. Consideration should be given to the
    relatively small skeletal and overjet improvements and perhaps this technique might be limited to
    those patients requiring smaller movements to achieve a positive overjet.
        The reduced perceived need for orthognathic surgery in the BAMPG is difficult to explain,
    particularly as our skeletal movements were smaller than those of other studies. However, the
    decision about perceived need for orthognathic surgery was taken at the DC3 timepoint. The
    DC3 values for ANB and overjet at DC3 would help explain the reduced perceived need for
    orthognathic surgery in the BAMPG. The ANB value for the BAMPG at DC3 was −2.4° and in
    the CG it was −3.9°. The final DC3 overjet in the BAMPG was −0.6 mm and in the CG it was
    −3.1 mm. This is supported by the descriptive statistic that 22% patients in the BAMPG had
    achieved a positive overjet at DC2, and at DC3, 37% had a positive overjet. The improvement in
    positive overjet DC2 to DC3 cannot be explained by upper or lower incisor inclination changes.
    It seems more likely that the skeletal effect of ANB improvement in the BAMP group is
    maintained at the 3-year follow-up and contributes to a more favourable overjet at DC3.
    Conclusion
    The BAMP technique did not show any social or psychological benefits; however, the skeletal
    class III improvements in ANB and overjet change were sufficient to reduce the perceived need
    for orthognathic surgery by 27%.
    Acknowledgments
    The authors thank Professor M Mommaerts, oral and maxillofacial surgeon, for his advice regarding
    surgical technique.
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                          26/07/24, 11 22 PM
                                                                                              Page 17 of 21
:
    The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or
    publication of this article.
    Funding
    The author(s) disclosed receipt of the following financial support for the research, authorship, and/or
    publication of this article: The trial was funded by the British Orthodontic Society Fund (BOSF) and by DB
    Orthodontics.
    ORCID iDs
    Nicky Mandall         https://orcid.org/0000-0003-4888-0804
    Richard Cousley         https://orcid.org/0000-0002-7393-4029
    Andrew DiBiase          https://orcid.org/0009-0003-5674-0630
    Note
    Trial registration Trial registry ISRCTN 93900866
    References
    Baccetti T, De Clerck HJ, Cevidanes LH, Franchi L (2010) Morphometric analysis of treatment effects of
        bone-anchored maxillary protraction in growing class III patients. European Journal of Orthodontics
        33: 121–125. Crossref. PubMed.
    Bjork A (1977) Growth of the maxilla in three dimensions as revealed radiographically by implant method.
        British Journal of Orthodontics 4: 53–64. Crossref. PubMed.
    Bjork A, Skieller V (1983) Normal and abnormal growth of the mandible. A synthesis of longitudinal
        cephalometric implant studies over a period of 25 years. European Journal of Orthodontics 5: 50–55.
    Cevidanes L, Baccetti T, Franchi L, McNamara JA Jr, De Clerck H (2010) Comparison of two protocols for
        maxillary protraction: Bone anchors versus face mask with rapid maxillary expansion. The Angle
        Orthodontist 80: 799–806. Crossref. PubMed.
    Cha BK, Ngan PW (2011) Skeletal anchorage for orthopedic correction of growing class III patients.
        Seminars in Orthodontics 17: 124–137. Crossref.
    Choi BH, Zhu SJ, Kim YH (2005) A clinical evaluation of titanium miniplates as anchors for orthodontic
        treatment. American Journal of Orthodontics and Dentofacial Orthopedics 128: 382–384. Crossref.
        PubMed.
    Cornelis MA, Scheffler NR, Mahy P, Siciliano S, De Clerck HJ, Tulloch JFC (2008a) Modified miniplates
        for temporary skeletal anchorage in orthodontics: Placement and removal surgeries. Oral Maxillofacial
        Surgery 66: 1439–1445. Crossref.
    Cornelis MA, Scheffler NR, Nyssen-Behets C, De Clerck HJ, Tulloch JFC (2008b) Patients’ and
        orthodontists’ perceptions of miniplates used for temporary skeletal anchorage: A prospective study.
        American Journal of Orthodontics and Dentofacial Orthopedics 133: 18–24. Crossref. PubMed.
    Cornelis MA, Tepedino M, DeVos Ris N, Niu X, Cattaneo PM (2021) Treatment effect of bone anchored
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                                  26/07/24, 11 22 PM
                                                                                                      Page 18 of 21
:
        maxillary protraction in growing patients compared to controls: A systematic review with meta-
        analysis. European Journal of Orthodontics 43: 51–68. Crossref. PubMed.
    De Clerck H, Cevidanes L, Baccetti T (2010) Dentofacial effects of bone-anchored maxillary protraction: A
        controlled study of consecutively treated class III patients. American Journal of Orthodontics and
        Dentofacial Orthopedics 138: 577–581. Crossref. PubMed.
    De Clerck H, Greerinks V, Siciliano S (2002) The zygoma anchorage system. Journal of Clinical
       Orthodontics 36: 455–459. PubMed.
    De Clerck H, Nuguyen T, de Paula LK, Cevidanes L (2012) Three-dimensional assessment of mandibular
        and glenoid fossa changes after bone-anchored class III intermaxillary traction. American Journal of
        Orthodontics and Dentofacial Orthopedics 142: 25–31. Crossref. PubMed.
    De Clerck HJ, Cornelis MA, Cevidanes LH, Heymann GC, Tulloch CJF (2009) Orthopedic traction of the
        maxilla with miniplates: A new perspective for treatment of midface deficiency. Journal of Oral
        Maxillofacial Surgery 67: 2123–2129. Crossref. PubMed.
    Elnagar MH, Elshourbagy E, Ghobashy S, Khedr M, Kusnoto B, Evans CA (2017a) Three-dimensional
        assessment of soft tissue changes associated with bone anchored maxillary protraction protocols.
        American Journal of Orthodontics and Dentofacial Orthopedics 152: 336–347. Crossref. PubMed.
    Elnagar MH, Elshourbagy E, Ghobashy S, Khedr M, Evans CA (2017b) Dentoalveolar and arch dimension
        changes in patients treated with miniplates-anchored maxillary protraction. American Journal of
        Orthodontics and Dentofacial Orthopedics 151: 1092–1106. Crossref. PubMed.
    Eroglu T, Katya B, Cetinsahin A, Arman A, Uckan S (2010) Success of zygomatic plate-screw anchorage
        system. Journal of Oral Maxillofacial Surgery 68: 602–605. Crossref. PubMed.
    Faco R, Yatabe M, Cevidanes LHS, Timmerman H, De Clerck HJ, Garib D (2019) Bone anchored
        maxillary protraction in unilateral cleft lip and palate: A cephalometric appraisal. European Journal of
        Orthodontics 41: 537–543. Crossref. PubMed.
    Feng X, Li J, Li Y, Zhao Z, Zhao S, Wang J (2012) Effectiveness of TAD-anchored maxillary protraction in
        late mixed dentition. The Angle Orthodontist 82: 1107–1114. Crossref. PubMed.
    Heymann GC, Crevidanes L, Cornelis M, De Clerck HJ, Tulloch JFC (2010) Three-dimensional analysis of
       maxillary protraction with the inter-maxillary elastics to miniplates. American Journal of Orthodontics
       and Dentofacial Orthopedics 137: 274–284. Crossref. PubMed.
    Javidi H, Trill BJ (2023) Orthodontics improves oral health-related quality of life: Fad, fact or fallacy?
         Orthodontic Update 16: 75–77. Crossref.
    Javidi H, Vettore M, Benson PE (2017) Does orthodontic treatment before the age of 18 years improve oral
         health-related quality of life? A systematic review and meta-analysis. American Journal of
         Orthodontics and Dentofacial Orthopedics 151(4): 644–655. Crossref. PubMed.
    Jokovic A, Locker D, Guyatt G (2006) Short forms of the Child Perceptions Questionnaire for 11-14 year-
        old children (CPQ11-14): Development and initial evaluation. Health and Quality of Life Outcomes 4:
        4. Crossref. PubMed.
    Jokovic A, Locker D, Stephens M, Kenny D, Tompson B, Guyatt G (2002) Validity and reliability of a
        questionnaire for measuring child oral health related quality of life. Journal of Dental Research 81:
        459–463. Crossref. PubMed.
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                                    26/07/24, 11 22 PM
                                                                                                        Page 19 of 21
:
    Kamel AH, Tarraf NE, Fouda AH, et al. (2023) Dentofacial effects of miniscrew-anchored maxillary
       protraction on prepuberty children with maxillary deficiency: A randomized controlled trial. Progress
       in Orthodontics 24: 22. Crossref. PubMed.
    Kircelli BH, Pektas ZO (2008) Midfacial protraction with skeletally anchored face mask therapy: A novel
         approach and preliminary anchored face mask therapy. American Journal of Orthodontics and
         Dentofacial Orthopedics 133: 440–449. Crossref. PubMed.
    Liou EJ (2005) Effective maxillary orthopaedic protraction for growing Class III patients: A clinical
        application simulates distraction osteo-genesis. Progress in Orthodontics 6: 154–171. PubMed.
    Mandall N, Cousley R, DiBiase A, Dyer F, Littlewood S, Mattick R, et al. (2016) Early class III protraction
       facemask reduces the need for orthognathic surgery: A multi-centre, two-arm parallel randomized
       controlled trial. Journal of Orthodontics 43: 164–175. Crossref. PubMed.
    Mandall NA, McCord JF, Blinkhorn AS, Worthington HV, O’Brien KD (2000) Perceived aesthetic impact
       of malocclusion and oral self perceptions in 14-15 year-old Asian and Caucasian children in Greater
       Manchester. European Journal of Orthodontics 22: 175–183. Crossref. PubMed.
    Mommaerts MY, Michiels ML, DePauw GA (2005) A 2-year outcome audit of a versatile orthodontic bone
       anchor. Journal of Orthodontics 32: 175–181. Crossref. PubMed.
    Mommaerts MY, Nols V, De Pauw G (2014) Long-term prospective study of an orthodontic bone anchor.
       The International Journal of Oral and Maxillofacial Implants 29: 419–426. Crossref. PubMed.
    Morales-Fernandez M, Iglesias-Linares A, Yanez-Vico RM, Mendoza-Mendoza A, Solano-Reina E (2013)
        Bone and dentoalveolar-anchored dentofacial orthopedics for class III malocclusion: New approaches
        similar objectives? A systematic review. Angle Orthodontist 83: 540–552. PubMed.
    Nguyen T, Cevidanes L, Cornelis MA, Heymann G, de Paula LK, De Clerck H (2011) Three-dimensional
        assessment of maxillary changes associated with bone anchored maxillary protraction. American
        Journal of Orthodontics and Dentofacial Orthopedics 140: 790–798. Crossref. PubMed.
    Quo A, Lo LF, Guilleminault C (2019) Maxillary protraction to treat pediatric obstructive sleep apnoea and
        maxillary retrusion: A preliminary report. Sleep Medicine 60: 60–68. Crossref. PubMed.
    Ren Y, Steegman R, Dieters A, Jansma J, Stamatakis H (2019) Bone anchored maxillary protraction in
        patients with unilateral complete cleft lip and palate and class III malocclusion. Clinical Oral
        Investigations 23: 2429–2441. Crossref. PubMed.
    Sar C, Arman-Ozcirpici A, Ucakn S, Yazici AC (2011) Comparative evaluation of maxillary protraction
        with or without skeletal anchorage. American Journal of Orthodontics and Dentofacial Orthopedics
        139: 636–649. Crossref. PubMed.
    Singer SL, Henry PJ, Rosenberger I (2000) Osseointegrated implants as an adjunct to facemask therapy: A
        case report. The Angle Orthodontist 70: 253–262. PubMed.
    Sugawara J, Nishimura M (2005) Minibone plates: The skeletal anchorage system. Seminars in
        Orthodontics 11: 47–56. Crossref.
    Van Hevele J, Nout E, Claeys T, Meyns J, Scheerlinck J (2018) Bone-anchored maxillary protraction to
        correct a class III skeletal relationship: A multicentre retrospective analysis of 218 patients. Journal of
        Cranio-Maxillo-Facial Surgery 46: 1800–1806. Crossref. PubMed.
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                                      26/07/24, 11 22 PM
                                                                                                         Page 20 of 21
:
    Yatabe M, Garib D, Faco R, de Clerck H, Souki B, Janson G, et al. (2017a) Mandibular and glenoid fossa
        changes after bone anchored maxillary protraction therapy in patients with UCLP: A 3-D preliminary
        assessment. The Angle Orthodontist 87: 423–431. Crossref. PubMed.
    Yatabe M, Garib DG, Faco RAS, de Clerck H, Janson G, Nguyen T, et al. (2017b) Bone-anchored maxillary
        protraction therapy in patients with unilateral complete cleft lip and palate: 3-dimensional assessment
        of maxillary effects. American Journal of Orthodontics and Dentofacial Orthopedics 152: 327–335.
        Crossref. PubMed.
https://journals.sagepub.com/doi/epub/10.1177/14653125241255139                                   26/07/24, 11 22 PM
                                                                                                       Page 21 of 21
: